Related Experiment Video

Updated: Jun 17, 2026

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
14:04

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria

Published on: May 8, 2013

24.4K

SWATH-MS Based Secretome Proteomic Analysis of Pseudomonas aeruginosa Against MRSA

Yi-Feng Zheng1, Yu-Sheng Lin1,2, Jing-Wen Huang1

  • 1Institute of Molecular Biology, National Chung Hsing University, Taichung, Taiwan.

Proteomics
|October 18, 2024
PubMed

Insights

Pseudomonas aeruginosa secretes specific proteins to combat methicillin-resistant Staphylococcus aureus (MRSA). SWATH-MS identified five key protein biomarkers, including Peptidase M23, aiding future antibacterial drug discovery.

Area of Science:

  • Microbiology
  • Proteomics
  • Biochemistry

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat due to its resistance to antibiotics.
  • Pseudomonas aeruginosa is an opportunistic pathogen with complex interactions within microbial communities.
  • Understanding the secreted proteins (secretome) of P. aeruginosa is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To identify key proteins secreted by Pseudomonas aeruginosa that exhibit inhibitory effects against methicillin-resistant Staphylococcus aureus (MRSA).
  • To leverage advanced proteomic techniques for a comprehensive analysis of bacterial secretomes.
  • To discover potential protein biomarkers for antibacterial research.

Main Methods:

  • Sequential Window Acquisition of All Theoretical Fragment Ion Mass Spectra (SWATH-MS) was employed for high-throughput secretome profiling.
  • Secretome proteomics was used to analyze the proteins released by P. aeruginosa.
  • Multivariate statistical methods were applied to filter and identify significant protein candidates.
  • Gene Ontology (GO) analysis and sequence alignment were performed to validate the functional roles of identified proteins.

Main Results:

  • SWATH-MS successfully profiled the secretome of P. aeruginosa in its interaction with MRSA.
  • Five potential protein biomarkers with antibacterial activity were identified, including Peptidase M23.
  • Variations in inhibition zones correlated with differences in MRSA strain resistance.
  • GO analysis and sequence alignment confirmed the antibacterial potential of the identified proteins.

Conclusions:

  • SWATH-MS is a powerful tool for comprehensive secretome analysis in bacterial interactions.
  • The identified protein biomarkers, such as Peptidase M23, offer promising targets for developing new treatments against MRSA.
  • This research provides a foundation for future investigations into P. aeruginosa-mediated antibacterial mechanisms.
Keywords:
Pseudomonas aeruginosaSWATH‐MSmethicillin‐resistant Staphylococcus aureusproteomicsscretome

More Related Videos

MS2-Affinity Purification Coupled with RNA Sequencing in Gram-Positive Bacteria08:34

MS2-Affinity Purification Coupled with RNA Sequencing in Gram-Positive Bacteria

Published on: February 23, 2021

6.6K
Proteomic Profile of EPS-Urine through FASP Digestion and Data-Independent Analysis14:48

Proteomic Profile of EPS-Urine through FASP Digestion and Data-Independent Analysis

Published on: May 8, 2021

6.9K

Related Concept Videos

Surface Membrane Barriers01:18

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...